| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-3128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-3118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-1787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31546 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142 |
| filingDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10860ef7c0b8da1fbb28b642315a24a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe78da8bbc5bae06414af29bf671911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2098e60f2a245cbbcd61fde2f0dd9e8 |
| publicationDate |
2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2714135-A2 |
| titleOfInvention |
Medicament delivery device and method of controlling the device |
| abstract |
A medicament delivery device is shown for the administration of one or more drug agents. The device has a priming mode and a drug delivery mode for administering delivery of the one or more drug agents. The device comprises a controller configured to set the device in a priming mode when one or more predetermined states of the device are identified and to disable the drug delivery mode during said predetermined state(s). When states of the device are different from said predetermined states, the controller can set the device in the drug delivery mode. A priming mode may still be enabled through a user interface. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571516-B2 |
| priorityDate |
2011-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |